Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic Review

por Cheng, Julia, Wu, Jashin J., Han, George
Publicado 2021

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability

por Manalo, Iviensan F, Gilbert, Kathleen E, Wu, Jashin J
Publicado 2015

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

por Huang, David B., Wu, Jashin J., Tyring, Stephen K.
Publicado 2004

A response to “Male balding is a major risk factor for severe COVID-19”

por Thatiparthi, Akshitha, Liu, Jeffrey, Martin, Amylee, Wu, Jashin J.
Publicado 2021

Preliminary outcomes of 2020-2021 dermatology residency application cycle and adverse effects of COVID-19

por Thatiparthi, Akshitha, Martin, Amylee, Liu, Jeffrey, Wu, Jashin J.
Publicado 2021

Effect Modification by Smoking Status on the Association Between Psoriasis and Chronic Obstructive Pulmonary Disease among Adults in the USA

por LIU, Jeffrey, MARTIN, Amylee, THATIPARTHI, Akshitha, WU, Jashin J.
Publicado 2021

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic

por Kearns, Donovan G., Uppal, Shelley, Chat, Vipawee S., Wu, Jashin J.
Publicado 2020

Applying to dermatology residency during the COVID-19 pandemic

por Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.
Publicado 2020

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic

por Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.
Publicado 2020

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”

por Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.
Publicado 2021

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review

por Thatiparthi, Akshitha, Martin, Amylee, Liu, Jeffrey, Egeberg, Alexander, Wu, Jashin J.
Publicado 2021

Psoriasis and Co-morbidity

por AMIN, Mina, LEE, Erica B., TSAI, Tsen-Fang, WU, Jashin J.
Publicado 2020

The risk of COVID-19 in patients with psoriasis: A retrospective cohort study

por Wu, Jashin J., Liu, Jeffrey, Thatiparthi, Akshitha, Martin, Amylee, Egeberg, Alexander
Publicado 2022

Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene...

por Adam, David N., Jablonski Bernasconi, Marie Y., Thoning, Henrik, Wu, Jashin J.
Publicado 2022

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

por Wu, Jashin J., Merola, Joseph F., Feldman, Steven R., Menter, Alan, Lebwohl, Mark
Publicado 2020

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

por Wu, Jashin J., Merola, Joseph F., Feldman, Steven R., Menter, Alan, Lebwohl, Mark
Publicado 2020

Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review

por Merola, Joseph F., Kavanaugh, Arthur, Lebwohl, Mark G., Gniadecki, Robert, Wu, Jashin J.
Publicado 2022

Economic Burden of Comorbidities in Patients with Psoriasis in the USA

por Wu, Jashin J., Suryavanshi, Manasi, Davidson, David, Patel, Vardhaman, Jain, Anuj, Seigel, Lauren
Publicado 2022

Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy

por Pithadia, Deeti J., Reynolds, Kelly A., Lee, Erica B., Liao, Wilson, Wu, Jashin J.
Publicado 2019

Biological and Clinical Basis for Molecular Studies of Interferons

por Pang, Katie R., Wu, Jashin J., Huang, David B., Tyring, Stephen K., Baron, Samuel
Publicado 2005